Exagen Inc. develops and commercializes various testing products based on its cell-bound complement activation products technology under the AVISE brand in the United States.
Exagen stock last closed at $4.43, down 1.34% from the previous day, and has increased 216.43% in one year. It has overperformed other stocks in the Diagnostics & Research industry by 2.47 percentage points. Exagen stock is currently +235.86% from its 52-week low of $1.32, and -28.78% from its 52-week high of $6.22.
There are currently 17.9M shares of XGN outstanding. The market cap of XGN is $79.29M. In the past 24 hours, 43,575 XGN shares were traded.
How to Buy Exagen Stock
Not sure how to invest in Exagen stock? Here's how.
Decide where to buy Exagen stock: You need to choose a stock brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you figure out where to buy Exagen stock.
Open a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Deposit funds into your brokerage account: Choose your method of payment and add your information.
Evaluate Exagen stock: The Exagen ticker symbol is XGN. Is Exagen stock a good investment? Should you buy shares of XGN? How do XGN's underlying business fundamentals look? Do top analysts think Exagen is a good buy? Why has XGN's stock price moved recently? (Hint: Our stock market research website can help you figure out if XGN is a good stock to buy).
Execute your XGN trade: Decide if you will purchase XGN shares at the current market price or use a limit order to buy XGN stock at a specific price.
Get the latest scoop on your XGN position: Create a watchlist to key updates about your new investment in Exagen stock.
Step 1: Decide where to buy Exagen stock
You will need a brokerage account in order to access the NASDAQ market and buy XGN shares.
A brokerage account is an investment account that allows you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
Invest in stocks with 0% commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you don't have the money to buy a full share, you can still purchase the stock.
Access to world markets: From Technology to Real Estate, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro has a community of more than 20 million users around the world. Talk to, learn from, and copy the crypto trades of top investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of shares by creating an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open a brokerage account
Now that you've picked your brokerage, you'll need to fill out some personal info so you are able to buy XGN stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Exagen stock
After you have identified the best place to buy Exagen stock, it's absolutely critical to evaluate their stock prior to investing, so you actually understand the risk as well as the opportunity.
Exagen quick stats
XGN Price
$4.43
1w %
-3.7%
1y %
216.43%
5y %
-70.87%
P/E
-5.34x
P/B
8.31x
P/S
1.45x
PEG
N/A
Revenue
$55.64M
Earnings
-$15.12M
Fore. Rev. Growth
15.38%
Fore. Earn. Growth
N/A
Market Cap
$79.29M
Next Earnings
May 12, 2025
Next Dividend
N/A
Exagen Fundamentals
WallStreetZen was designed to help everyday investors do more accurate fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on XGN's stock page.
Is XGN stock properly valued?
Investors use many financial metrics, analyses, models, and charts to gauge XGN's true value.
Using relative valuations ratios:
XGN could be overvalued based on its P/B ratio of 8.31x, relative to Diagnostics & Research industry P/B ratio of 3.22x
XGN has cash burn of 13794000. It has enough cash and short-term investments to cover this for at least one year.
There are more short-term assets than long-term liabilities on the XGN balance sheet.
There are more short-term assets than short-term liabilities on the XGN balance sheet.
XGN has $22.04M in cash and short term investments. This is enough to cover its annual cash burn of $13.79M.
Failed Health Checks:
XGN profit margin has gone up by 0.18 percentage points in the past year, but the company is still unprofitable.
XGN has a relatively high debt to equity ratio of 3.68.
Total XGN debt is higher than 5 years ago, relative to shareholder equity.
Do Wall Street analysts think it's a good time to buy Exagen stock
Out of 2 sell side analysts who monitor XGN, the consensus analyst rating on XGN is a Strong Buy
It's important to note that analyst ratings are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are forecasting on the Exagen stock forecast page.
XGN Trading Indicators
SMA10
4.34
SMA20
4.19
SMA50
3.89
SMA100
4.09
SMA200
3.4
MACD
0.19
MACD Signal
0.16
MACD Histogram
0.03
RSI
56.94
Stochastic %K
76.37
Stochastic %D
81.14
StochRSI %K
70.09
StochRSI %D
75.61
XGN Growth Numbers
Last year, XGN revenue was $55.64M. In the last five year, XGN's revenue has increased by 6.62% per year. This was slower than the Diagnostics & Research industry average of 9.93%.
No, Exagen doesn't provide an income stream by paying out dividends.
What do other investors have to say about XGN?
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other traders have to say.
Step 5: Execute your XGN trade
You have two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are mostly sufficient.
Limit order: A limit order lets you buy or sell a security at a specific price (or better). If you want to be sure you're buying or selling at a particular price limit, place a limit order.
Hit the Open button and eToro will execute your order.
If you require additional help investing in stocks on eToro, watch the helpful video below:
As of Apr 21, 2025, it costs $4.43 to buy one share of Exagen stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $2, you can buy 0.451 shares of XGN.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.